Adding new hypertensive to treatment may have greater effect on systolic #bloodpressure than maximizing dose. @medpagetoday@cphend: https://t.co/yMeGxotqnr
A web app helped people determine whether they should be on a statin with high concordance to physicians' determinations, reported Steven Nissen, MD, in @JACCJournals.
By @cphend, @MedPageCardio. #cardiotwitter@ACCinTouch
https://t.co/Icc7Yy41Ay
Hurricane Ida didn't become a full-fledged dialysis disaster in part due to the lessons from Hurricane Katrina, but there are bigger challenges ahead.
W/comment from @kramer_holly. By @cphend.
https://t.co/PQwEPyVivw
Plasma transfusions from COVID-19-recovered patients didn't prevent progression of the same infection in high-risk adults outside the hospital setting, reported Clifton Callaway, MD, PhD, in @NEJM.
By @cphend. #IDtwitter
https://t.co/vC61tVOhJi
Younger kids will need #CovidVaccine, FDA advisors agreed. But yesterday's panel was torn over how quickly -- relying on emergency use authorization vs waiting for data needed for full licensure @medpagetoday@MedPageID https://t.co/DWWwR2Tuar
#COVID19 vaccine: Study on CVST "spells out what we've all been saying...The bottom line is the risk-benefit continues to be clearly in favor of being vaccinated." @MaryCushmanMD@bbikdeli
Younger teens may not be as likely to have severe #COVID19 as adults, but their hospitalization rates spiked early this year and left a large proportion in critical care, reported in @CDCMMWR.
By @cphend
https://t.co/UVa8DVRbIB
For low-risk breast cancer patients getting potentially cardiotoxic treatment, candesartan's short-term protection of cardiac function faded longer term in the PRADA trial from #ACC21. @medpagetoday@cphend: https://t.co/T4TRBqGqgu #CardioOnc
Having a previous thrombosis or thrombophilia (sticky blood) is not a risk factor for developing the rare post COVID-19 vaccine thrombosis & thrombocytopenia
Discussing this at the highest level now!
Monoclonal antibody bamlanivimab appeared to work for end-stage renal disease patients in early data from dialysis providers, but there are plenty of questions that remain. By @cphend.
https://t.co/eZ74jjYcRF
Study finds fewer than 20% of solid organ transplant patients mounted detectable antibodies to SARS-CoV-2 following a first dose of COVID-19 vaccine.
@medpagetoday 's @MartyMakary asks author @Dorry_Segev about the findings and implications of his study.
https://t.co/h0UByRFG2X
For ICU, prophylactic-dose anticoagulation continues shaping up as best option for COVID-19 @bbikdeli@MaryCushmanMD@PlateletDoc https://t.co/CooBfNf32w